The Only Complete Online Marketing Firm
Thursday, August 27, 2015
Tasigna Shows Promise in Systemic Sclerosis (CME/CE)
(MedPage Today) -- Skin scores improved at 12 months, but tolerability limited by mild QTc prolongation
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment